DXCM (DXCM) Stock Analysis

DXCM (DXCM) is a publicly traded company in the HEALTHCARE sector. It trades at $73.45, carries a market capitalization of $28.45B, a price-to-earnings ratio of 31.65. This page summarizes the public market data, fundamentals, and frequently asked questions for DXCM, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $73.45
• Market Cap: $28.45B
• P/E Ratio: 31.65
• EPS: $2.33
• 52-Week High: $89.98
• 52-Week Low: $54.11

Market Sentiment

DXCM currently has a Bullish sentiment score of 0.19.

About DXCM

DexCom, Inc. is a prominent leader in diabetes care, renowned for its groundbreaking continuous glucose monitoring (CGM) systems that empower patients to manage their diabetes effectively. Headquartered in San Diego, California, with a strategic manufacturing facility in Mesa, Arizona, the company is dedicated to advancing diabetes management through innovative technology and exceptional product quality. As a pioneer in glucose monitoring, DexCom is actively expanding its global presence to m...

GNG Research Analysis

GNG Research scores DXCM (DXCM) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for DXCM.

Frequently Asked Questions

Does DXCM pay dividends?

DXCM (DXCM) does not currently pay a regular dividend.

What is DXCM's P/E ratio?

DXCM has a price-to-earnings (P/E) ratio of 31.65.

What is DXCM's market cap?

DXCM (DXCM) has a market capitalization of $28.45B with a current stock price of $73.45.